Even though the major market indexes rallied in impressive fashion, most Sector Leaders gave a lackluster showing Tuesday. Some turned tail or failed to keep pace with the market. Jazz Pharmaceuticals (JAZZ) fell 0.87 to 59.13 in more than three times average trade, ending a five-session win streak. Early Tuesday, the drugmaker priced a secondary offering of 5.375 million shares at $58.50 a piece -- a 2.5% discount to Tuesday's close. LinkedIn